Navigation Links
Mentice Appoints Bjorn Larsson as Vice President of Global Marketing
Date:10/13/2008

GOTHENBURG, Sweden, October 13 /PRNewswire/ -- Mentice, a leading supplier of solutions for medical simulation, announces the appointment of Mr. Bjorn Larsson as Vice President of Global Marketing.

Effective from today Mr. Bjorn Larsson will head up and coordinate Mentice's marketing activities globally from a corporate standpoint.

Mr. Larsson brings to Mentice over 15 years of experience of global sales, marketing and product management within pharmaceuticals and medical technology in areas including cardiology, stroke management and CNS. Before joining Mentice, he held global leadership positions at well renowned companies like Astra Zeneca, Novo Nordisk, Medtronic and Astra Tech. Mr. Larsson holds an MSc in Mechanical Engineering.

"Medical simulation is today widely endorsed for enhancing skills, improving clinical outcome and patient safety" says Mr Bjorn Larsson, Vice President of Global Marketing. He continues: "Mentice is uniquely positioned to further strengthen its leadership in this field. We are determined to provide the most innovative medical simulation solutions as an integral part of physician training and education."

"Bjorn's extensive background in the pharmaceutical and med-tech areas will clearly be a great contribution to our organisation and will help to strengthen our position in the global market place." says Goran Malmberg, President/CEO of Mentice.

Mentice - Improving Patient Safety

Mentice is a world leader in medical simulation, providing qualified solutions for training, education and assessment of medical professionals. With a focus on minimally invasive techniques and procedures, Mentice develops simulation systems for training in a virtual environment within the fields of endovascular intervention and endoscopic surgery. Mentice's solutions have documented effects of improving participants' learning, reducing costs, enhancing training effectiveness and eventually, improving patient safety.

For further information, please contact Goran Malmberg, President/CEO of Mentice, Phone: +46-31-33-99-401.


'/>"/>
SOURCE Mentice AB
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Mentice AB Announces Leadership Changes Within Its Worldwide Operations
2. Mentice AB Announces the Appointment of Lars Lonn as Clinical Director for Mentice
3. Mentice, Inc. and the Milwaukee Area Technical College (MATC) Announce Their Partnership in the Area of Procedural Medical Simulation
4. Mentice, Inc. and Education Management Solutions, Inc. Form OEM Partnership
5. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
6. Codexis Appoints Singapore Laboratories Managing Director
7. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
8. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
11. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... Kara Dwyer Dodge grew up hearing stories of the sea ... in Scituate, Mass., found a sea turtle entangled in the lines of one of his ... a minor sensation because no one could remember ever seeing one so large so close ...
(Date:12/6/2016)... ... 06, 2016 , ... The Osteoarthritis Research Society International (OARSI) ... (FDA) to consider OA as a serious disease. As an organization of professionals ... of OA patients, many of whom may experience progressive disability and decreased quality ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... today announced it has acquired the assets of Theorem Clinical Research - ... focuses on clinical trial drug packaging, labeling, storage, reconciliation, and distribution for ...
(Date:12/6/2016)... PARK, Calif. , Dec. 6, 2016 /PRNewswire/ ... up to $150 million from the National Institutes ... Diseases and the Division of AIDS (NIAID-DAIDS) to ... and other non-vaccine pre-exposure (PreP) agents. Under the ... of preclinical product development services for candidate HIV-prevention ...
Breaking Biology Technology:
(Date:11/21/2016)... , Nov. 21, 2016   Neurotechnology , ... recognition technologies, today announced that the MegaMatcher On ... was submitted for the NIST Minutiae Interoperability ... all the mandatory steps of the evaluation protocol. ... a continuing test of fingerprint templates used to ...
(Date:11/15/2016)... Md. , Nov. 15, 2016  Synthetic ... company developing therapeutics focused on the gut microbiome, ... offering of 25,000,000 shares of its common stock ... common stock at a price to the public ... proceeds to Synthetic Biologics from the offering, excluding ...
(Date:6/22/2016)... 22, 2016  The American College of Medical Genetics and ... Magazine as one of the fastest-growing trade shows during ... the Bellagio in Las Vegas . ... of growth in each of the following categories: net square ... number of attendees. The 2015 ACMG Annual Meeting was ranked ...
Breaking Biology News(10 mins):